Dimensional Fund Advisors
ELOX

Dimensional Fund Advisors’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Dimensional Fund Advisors’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-529
Closed -$70K – 3487
2021
Q1 		$70K Hold
529
– – ﹤0.01% 3378
2020
Q4 		$84K Hold
529
– – ﹤0.01% 3287
2020
Q3 		$56K Hold
529
– – ﹤0.01% 3302
2020
Q2 		$64K Buy
529
+91
+21% +$10.3K ﹤0.01% 3304
2020
Q1 		$34K Buy
+438
New +$71.3K ﹤0.01% 3339

Other funds holding ELOX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Dimensional Fund Advisors's ELOX Position: Q2 2021 in Review

Dimensional Fund Advisors sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q2 2021, closing a stake of 529 shares — an estimated $70K sold.

Dimensional Fund Advisors first reported a position in ELOX in Q1 2020 and held it in 5 quarters. The position peaked at $84K in Q4 2020. 46 funds tracked by Wall St. Rank hold ELOX as of Q2 2021.

  • Dimensional Fund Advisors reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Dimensional Fund Advisors sold 529 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $70K.
  • Dimensional Fund Advisors first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 5 quarters.
  • Dimensional Fund Advisors's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $84K in Q4 2020.
  • 46 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Dimensional Fund Advisors's 13F filing for Q2 2021, filed 12 Aug 2021.